Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Infantile Spasms Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Infantile Spasms Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Infantile Spasms Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GW Pharmaceuticals
Insys Therapeutics
Valerion Therapeutics
Orphelia Pharma
Anavex Life Sciences
Mallinckrodt
H Lundbeck
Catalyst Pharmaceuticals
Retrophin
By Type:
Oral
Injection
By End-User:
Hospital
Clinic
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Infantile Spasms Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Infantile Spasms Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 USA Infantile Spasms Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Infantile Spasms Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Infantile Spasms Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Injection
4 Segmentation of Infantile Spasms Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Infantile Spasms Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Infantile Spasms Therapeutics in Hospital
-
4.4.2 Market Size and Growth Rate of Infantile Spasms Therapeutics in Clinic
5 Market Analysis by Regions
-
5.1 USA Infantile Spasms Therapeutics Production Analysis by Regions
-
5.2 USA Infantile Spasms Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Infantile Spasms Therapeutics Landscape Analysis
-
6.1 West USA Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
7 South USA Infantile Spasms Therapeutics Landscape Analysis
-
7.1 South USA Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Infantile Spasms Therapeutics Landscape Analysis
-
8.1 Middle West USA Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Infantile Spasms Therapeutics Landscape Analysis
-
9.1 Northeast USA Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GW Pharmaceuticals
-
10.1.1 GW Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Insys Therapeutics
-
10.2.1 Insys Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Valerion Therapeutics
-
10.3.1 Valerion Therapeutics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Orphelia Pharma
-
10.4.1 Orphelia Pharma Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Anavex Life Sciences
-
10.5.1 Anavex Life Sciences Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Mallinckrodt
-
10.6.1 Mallinckrodt Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 H Lundbeck
-
10.7.1 H Lundbeck Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Catalyst Pharmaceuticals
-
10.8.1 Catalyst Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Retrophin
-
10.9.1 Retrophin Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Infantile Spasms Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure USA Infantile Spasms Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Infantile Spasms Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Infantile Spasms Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Infantile Spasms Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Infantile Spasms Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Infantile Spasms Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Infantile Spasms Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Table USA Infantile Spasms Therapeutics Production by Regions
-
Table USA Infantile Spasms Therapeutics Production Share by Regions
-
Figure USA Infantile Spasms Therapeutics Production Share by Regions in 2016
-
Figure USA Infantile Spasms Therapeutics Production Share by Regions in 2021
-
Figure USA Infantile Spasms Therapeutics Production Share by Regions in 2027
-
Table USA Infantile Spasms Therapeutics Consumption by Regions
-
Table USA Infantile Spasms Therapeutics Consumption Share by Regions
-
Figure USA Infantile Spasms Therapeutics Consumption Share by Regions in 2016
-
Figure USA Infantile Spasms Therapeutics Consumption Share by Regions in 2021
-
Figure USA Infantile Spasms Therapeutics Consumption Share by Regions in 2027
-
Table West USA Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table West USA Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table South USA Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GW Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of GW Pharmaceuticals
-
Figure Revenue and Market Share Analysis of GW Pharmaceuticals
-
Table Product and Service Introduction of GW Pharmaceuticals
-
Table Company Profile and Development Status of Insys Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insys Therapeutics
-
Figure Sales and Growth Rate Analysis of Insys Therapeutics
-
Figure Revenue and Market Share Analysis of Insys Therapeutics
-
Table Product and Service Introduction of Insys Therapeutics
-
Table Company Profile and Development Status of Valerion Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valerion Therapeutics
-
Figure Sales and Growth Rate Analysis of Valerion Therapeutics
-
Figure Revenue and Market Share Analysis of Valerion Therapeutics
-
Table Product and Service Introduction of Valerion Therapeutics
-
Table Company Profile and Development Status of Orphelia Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphelia Pharma
-
Figure Sales and Growth Rate Analysis of Orphelia Pharma
-
Figure Revenue and Market Share Analysis of Orphelia Pharma
-
Table Product and Service Introduction of Orphelia Pharma
-
Table Company Profile and Development Status of Anavex Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anavex Life Sciences
-
Figure Sales and Growth Rate Analysis of Anavex Life Sciences
-
Figure Revenue and Market Share Analysis of Anavex Life Sciences
-
Table Product and Service Introduction of Anavex Life Sciences
-
Table Company Profile and Development Status of Mallinckrodt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt
-
Figure Sales and Growth Rate Analysis of Mallinckrodt
-
Figure Revenue and Market Share Analysis of Mallinckrodt
-
Table Product and Service Introduction of Mallinckrodt
-
Table Company Profile and Development Status of H Lundbeck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck
-
Figure Sales and Growth Rate Analysis of H Lundbeck
-
Figure Revenue and Market Share Analysis of H Lundbeck
-
Table Product and Service Introduction of H Lundbeck
-
Table Company Profile and Development Status of Catalyst Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Catalyst Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Catalyst Pharmaceuticals
-
Table Product and Service Introduction of Catalyst Pharmaceuticals
-
Table Company Profile and Development Status of Retrophin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Retrophin
-
Figure Sales and Growth Rate Analysis of Retrophin
-
Figure Revenue and Market Share Analysis of Retrophin
-
Table Product and Service Introduction of Retrophin
-
